Esomeprazole Pd.I.S.Inf 40mg/Vial (EU CTD Available)

Product description

Esomeprazole 40 mg/Vial Powder for Solution for Injection/Infusion
Reference Product: Nexium® / Pfizer
Description: Esomeprazole is a proton pump inhibitor indicated for the treatment of the Gastroesophageal Reflux Disease (GERD) with erosive esophagitis (EE) in adults and pediatric patients greater than one month of age, when oral therapy is not possible or appropriate and the Risk Reduction of Rebleeding of Gastric or Duodenal Ulcers following therapeutic endoscopy in adults. 
Dossier Status: EU CTD Available
Stability Studies: Zone II / Zone IVb
Shelf life: Two (2) years
Batch Sizes: 40,000 vials
Pack Sizes: BT x 1 vial & x 10 vials
Read more


Categories Finished Dosage FormsInjectables; Contract Services - Contract ServicesLyophilisation; Finished Dosage FormsOut-licensing
Sales markets Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia)
Supplied from Greece
Selling Points International Approvals/Standards

More products from ANFARM HELLAS S.A.

View all our products (37)
Esomeprazole Pd.I.S.Inf 40mg/Vial (EU CTD Available)

Contact information




View all contact information
Curia - From Curiosity to Cure

Curia - From Curiosity to Cure

Datwyler Pharma Packaging

Datwyler Pharma Packaging

Alfasigma  Contract Manufacturing Showroom

Alfasigma Contract Manufacturing Showroom